首页> Oncotarget> Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation <i>BRCA1</i> L63X.

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation <i>BRCA1</i> L63X.

导出 OA

翻译打印收藏纠错

第一作者： Reiko,Yoshida

第一单位： Division of Clinical Genetic Oncology, Cancer Institute Hospital, Tokyo, Japan.;Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo, Japan.

作者： Reiko,Yoshida ^[1] ; Chie,Watanabe ^[2] ; Shiro,Yokoyama ^[3] ; Mayuko,Inuzuka ^[3] ; Junko,Yotsumoto ^[3] ; Masami,Arai ^[4] ; Seigo,Nakamura ^[5] ; Registration Committee of the Japanese HBOC consortium

作者单位： Division of Clinical Genetic Oncology, Cancer Institute Hospital, Tokyo, Japan.;Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo, Japan. ^[1] Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo, Japan.;Department of Nursing, Faculty of Human Sciences, Sophia University, Tokyo, Japan. ^[2] Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo, Japan. ^[3] Division of Clinical Genetic Oncology, Cancer Institute Hospital, Tokyo, Japan. ^[4] Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo, Japan.;The 3rd Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China. ^[5]

关键词 BRCA1 L63X c.188T>A founder mutation hereditary breast and ovarian cancer

DOI 10.18632/oncotarget.26852

PMID 31143373

发布时间 2020-02-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交